跳至主要内容
临床试验/NCT04027777
NCT04027777招募中不适用

Single-center Prospective Observational Study to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Double Auscultation

Aktiia SA2 个研究点 分布在 1 个国家目标入组 355 人开始时间: 2019年8月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Aktiia SA
入组人数
355
试验地点
2
主要终点
Blood Pressure absolute Mean Error

研究概览

简要总结

Single-centre prospective observational study to validate the performance of the Aktiia SA optical blood pressure monitoring (OBPM) device at the wrist against blood pressure measurements obtained by double auscultation at the upper arm during four weeks

详细描述

According to the World Health Organization, by 2025 hypertension will affect 1.5 billion adults worldwide. Half of the adult population is not diagnosed, and half of the treated population is not at the defined target of BP. Widespread use of out of office BP measurement is one of the proposed strategies to fight against hypertension worldwide.

The current Ambulatory Blood Pressure Monitoring or Home Blood Pressure Monitoring are performed with a cuff placed around the arm. This 110-year-old technology is not only uncomfortable for the patient but can also result in a number of overestimated readings due to the stress induced while inflating the cuff.

Aktiia S.A. has developed an intermittent automated non-invasive cuffless blood pressure monitor determining over a series of cardiac cycles the values of the systolic blood pressure, the diastolic blood pressure and the heart rate. This miniature device is comfortably positioned with a bracelet on a user's wrist. The optical sensors integrated within the device exploit the principle of reflection photoplethysmography (PPG) to capture the user's skin pulsatility (change of arterial diameter occurring at each heartbeat). Aktiia OBPM algorithms are further applied to the recorded PPG signal to determine user's blood pressure and heart rate.

Because the measurement relies on optical sensors, and not on pneumatic cuffs, Aktiia OBPM device provides an increased overall comfort to the patient throughout the monitoring, does not induce sleep arousal during the night measurements and decreases the false positive readings induced by the stress associated with the cuff inflation. Aktiia OBPM device is intended to be used in the long term, as compared to one-day or one-week use of Ambulatory Blood Pressure Monitors.

This study over several visits has been designed to assess both the accuracy and the stability of the Aktiia OBPM. The automaticity of the measurement when performed in different body positions and upon aerobic exercise was also evaluated.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
21 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion Criteria:
  • Adult subjects (aged between 21 and 65 years old)
  • Subjects fluent in written and spoken French
  • Subjects agreeing to attend the totality of 4 visits
  • Subjects that have signed the informed consent form

排除标准

  • Subjects with tachycardia (heart rate at rest > 120bpm)
  • Subjects with atrial fibrillation
  • Subjects with diabetes
  • Subjects with renal dysfunctions (eGFR < 60mL/min/1.73 m2)
  • Subjects with hyper-/hypothyroidism
  • Subjects with pheochromocytoma
  • Subjects with Raynaud's disease
  • Subjects with trembling and shivering
  • Subjects with interarm systolic difference > 15 mmHg
  • Subjects with interarm diastolic difference > 10 mmHg
  • Subjects with arm paralysis
  • Women in known pregnancy
  • Subjects with an arteriovenous fistula
  • Subjects with arm amputations
  • Subjects with the upper arm circumference > 64 cm
  • Subjects with the wrist circumference > 22 cm (limitation due Aktiia.bracelet-P0 size)
  • Subjects with the central phalanx of the middle finger circumference > 71 mm or < 43 mm
  • Subjects with the exfoliative skin diseases (limitation due to participant discomfort)
  • Subjects with lymphoedema (limitation due to participant discomfort)
  • Inclusion Criteria:
  • Adult subjects (aged between 21 and 65 years old)
  • Subjects fluent in written and spoken French
  • Subjects agreeing to attend the totality of 4 visits
  • Subjects that have signed the informed consent form
  • Exclusion Criteria:
  • Subjects with tachycardia (heart rate at rest > 120bpm)
  • Subjects with atrial fibrillation
  • Subjects with hyper-/hypothyroidism
  • Subjects with pheochromocytoma
  • Subjects with Raynaud's disease
  • Subjects with trembling and shivering
  • Subjects with interarm systolic difference > 15 mmHg
  • Subjects with interarm diastolic difference > 10 mmHg
  • Subjects with arm paralysis
  • Women in known pregnancy
  • Subjects with an arteriovenous fistula
  • Subjects with arm amputations
  • Subjects with the upper arm circumference > 64 cm
  • Subjects with the wrist circumference > 22 cm (limitation due Aktiia.bracelet-P0 size)
  • Subjects with the central phalanx of the middle finger circumference > 71 mm or < 43 mm
  • Subjects with the exfoliative skin diseases (limitation due to participant discomfort)
  • Subjects with lymphoedema (limitation due to participant discomfort)
  • Inclusion Criteria:
  • Adult subjects (aged between 65 and 85 years old)
  • Subjects fluent in written and spoken French
  • Subjects agreeing to attend the totality of 4 visits
  • Subjects that have signed the informed consent form
  • Exclusion Criteria:
  • Subjects with tachycardia (heart rate at rest > 120bpm)
  • Subjects with atrial fibrillation
  • 另有 126 项未显示

研究组 & 干预措施

Aktiia.product-P0 and subjects with Chronic Kidney disease

Experimental

Additional study arm including 40 subjects with chronic kidney disease (ARM 4)

干预措施: Aktiia.product-P0 (Device)

Aktiia.product-P0

Experimental

Main study arm including 105 subjects

干预措施: Aktiia.product-P0 (Device)

Aktiia.product-P0 Diabetics

Experimental

Second study arm including 40 diabetic patients

干预措施: Aktiia.product-P0 (Device)

Aktiia.product-P0 Aged

Experimental

Thirs study arm including 40 patients aged 65+

干预措施: Aktiia.product-P0 (Device)

Aktiia.product-P0 and subjects with Heart Failure

Experimental

Additional study arm including 40 subjects with Heart Failure (ARM 5)

干预措施: Aktiia.product-P0 (Device)

Aktiia.product-P0 and Pregnant subjects

Experimental

Additional study arm including 50 pregnant subjects (ARM 6)

干预措施: Aktiia.product-P0 (Device)

Aktiia.product-P0 and subjects in Post partum

Experimental

Additional study arm including 40 subjects in post partum (ARM 7)

干预措施: Aktiia.product-P0 (Device)

结局指标

主要结局

Blood Pressure absolute Mean Error

时间窗: Up to four weeks

The absolute value of the mean of the differences between Reference and Aktiia.product-P0 blood pressure determinations

Blood Pressure standard Deviation of the Error

时间窗: Up to four weeks

The standard deviation of the differences between Reference and Aktiia.product-P0 determinations

次要结局

  • Heart Rate root-mean-square error(Up to four weeks)

研究者

发起方
Aktiia SA
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验